http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4451571-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_694f42f9997b742ece8b3b51568bd507
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-25125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-82
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
filingDate 1981-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1984-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e34b0d1217312c6df8a2a63ec846335
publicationDate 1984-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4451571-A
titleOfInvention Preparation of samples for vitamin B12 and/or folate assay and assay
abstract Vitamin B12 (cobalamin) and/or folate (folic acid) assay techniques can be simplified, by eliminating the step of heating or boiling the to-be-tested sample prior to its assay. This is accomplished by utilizing compositions and procedures: (1) which substantially completely liberate all vitamin B12 and/or folate from endogenous binding protein without heating or boiling; (2) which substantially completely destroy all endogenous binding protein which is present in the to-be-assayed sample, and which may bind natural and radioactive vitamin B12 or folate both due to its liberation from vitamin B12 or folate in the original sample or due to its unbound presence in the original sample; (3) which substantially completely inhibit or block any undestroyed endogenous binding protein; and (4) which substantially completely inhibit or destroy any intrinsic factor-blocking antibodies which may be present in the to-be-assayed sample. In preferred embodiments the protein destroying compositions utilized include both a strong base and a sulfhydral compound which is a strong disulfide protein destroying material while the material of choice to bind with undestroyed endogenous binding protein is a vitamin B12 analogue. The sample is then assayed using known, for example, radioisotrope dilution assay techniques.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5187107-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007207136-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006009874-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05232110-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7674490-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6673381-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4680273-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7172778-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6887669-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6159698-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6451360-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5434087-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5310656-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4940658-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4950612-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6808725-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6942977-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5506109-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8431561-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008227746-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113189252-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6555388-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8905975-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07104348-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006009874-A3
priorityDate 1981-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4333918-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4279859-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4355018-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4166104-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4271140-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4166103-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4300907-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4146602-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3981863-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4188189-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4351822-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4332786-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4225784-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128926318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129475383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135444779

Total number of triples: 63.